Sanofi India Ltd

Sanofi India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sanofi India Ltd

₹ 6,371 0.34%
22 Jul - close price
sanofiindialtd.com BSE: 500674 NSE: SANOFI
About

Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.

Key Points

India - Branded generics (79% of CY20 revenues):[1] Top-7 brands contribute ~70% of domestic sales and are growing at high single digits.[2]

Website BSE NSE
  • Market Cap ₹ 14,655 Cr.
  • Current Price ₹ 6,371
  • High / Low ₹ 7,540 / 4,208
  • Stock P/E 25.8
  • Book Value ₹ 441
  • Dividend Yield 2.62 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 14.4 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024
706 715 694 732
528 506 506 514
Operating Profit 178 208 187 219
OPM % 25% 29% 27% 30%
16 12 12 -20
Interest 1 0 0 0
Depreciation 10 10 10 10
Profit before tax 183 210 189 188
Tax % 33% 28% 27% 27%
123 152 138 137
EPS in Rs 53.43 66.04 59.87 59.39
Raw PDF
Upcoming result date: 26 July 2024

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 TTM
2,851 2,847
2,044 2,054
Operating Profit 807 793
OPM % 28% 28%
79 19
Interest 2 2
Depreciation 40 40
Profit before tax 846 770
Tax % 29%
603 549
EPS in Rs 262.13 238.73
Dividend Payout % 64%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: 13%
5 Years: 11%
3 Years: 9%
1 Year: 50%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023
Equity Capital 23
Reserves 992
19
681
Total Liabilities 1,715
315
CWIP 16
Investments 0
1,384
Total Assets 1,715

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023
230
38
-878
Net Cash Flow -610

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023
Debtor Days 17
Inventory Days 202
Days Payable 89
Cash Conversion Cycle 130
Working Capital Days 25
ROCE %

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40%
10.34% 9.22% 8.99% 8.71% 8.26% 6.99% 6.71% 6.72% 6.80% 6.31% 6.11% 5.81%
17.67% 19.05% 18.65% 18.59% 18.28% 19.22% 19.46% 19.65% 21.68% 22.51% 22.88% 22.60%
11.59% 11.33% 11.96% 12.30% 13.08% 13.41% 13.43% 13.22% 11.10% 10.78% 10.61% 11.21%
No. of Shareholders 51,64650,91659,27664,54273,73474,59376,69471,51368,59862,87061,84967,662

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls